Metabolic syndrome in patients receiving antipsychotic therapy

被引：0
|
作者：
Le Guillouzic, D. [1 ]
机构：
[1] Hop Paul Guiraud, Villejuif, France
来源：
CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION | 2011年 / 15卷 / 04期
关键词：
Metabolic syndrome; Visceral adiposity; Insulin resistance; Severe mental disorders; Antipsychotic; DRUG-NAIVE PATIENTS; ATYPICAL ANTIPSYCHOTICS; GLUCOSE-TOLERANCE; WEIGHT-GAIN; SCHIZOPHRENIA; PREVALENCE; RISPERIDONE; OLANZAPINE; DISEASE; RISK;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：101 / 106
页数：6
相关论文
共 50 条
  • [21] Clinical monitoring and management of the metabolic syndrome in patients receiving atypical antipsychotic medications
    Hasnain, Mehrul
    Vieweg, W. Victor R.
    Fredrickson, Sonja K.
    Beatty-Brooks, Mary
    Fernandez, Antony
    Pandurangi, Anand K.
    PRIMARY CARE DIABETES, 2009, 3 (01) : 5 - 15
  • [22] The frequency of metabolic syndrome in patients with schizophrenia and schizoaffective disorder
    Oyekcin, Demet Gulec
    ANADOLU PSIKIYATRI DERGISI-ANATOLIAN JOURNAL OF PSYCHIATRY, 2009, 10 (01): : 26 - 33
  • [23] Prevalence of Metabolic Syndrome in Patients with Schizophrenia in Korea: A Multicenter Nationwide Cross-Sectional Study
    Lee, Jung Sun
    Kwon, Jun Soo
    Kim, Daeho
    Kim, Sung-Wan
    Kim, Jae-Jin
    Kim, Jong-Noon
    Nam, Hee Jung
    Ryu, Seunghyong
    Park, Il Ho
    An, Suk Kyoon
    Oh, Hong-Seok
    Won, Seunghee
    Lee, Kanguk
    Lee, Young
    Lee, Seung-Hwan
    Lee, Yu Sang
    Yi, Jung-Seo
    Hong, Kyung Sue
    Joo, Yeon Ho
    PSYCHIATRY INVESTIGATION, 2017, 14 (01) : 44 - 50
  • [24] Racial/Ethnic Disparities in Monitoring Metabolic Parameters for Patients with Schizophrenia Receiving Antipsychotic Medications
    Phillips, Karon L.
    Copeland, Laurel A.
    Zeber, John E.
    Stock, Eileen M.
    Tsan, Jack Y.
    MacCarthy, Andrea A.
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2015, 23 (06) : 596 - 606
  • [25] Metabolic Risks in Older Adults Receiving Second-Generation Antipsychotic Medication
    Brooks, John O., III
    Chang, Hye-Sang
    Krasnykh, Olya
    CURRENT PSYCHIATRY REPORTS, 2009, 11 (01) : 33 - 40
  • [26] Does the metabolic syndrome affect the effectiveness of antipsychotic therapy for different durations of schizophrenia?
    Kornetova, E.
    Kornetov, A.
    Ivanova, S.
    EUROPEAN PSYCHIATRY, 2020, 63 : S246 - S246
  • [27] Atypical Antipsychotic Drugs, Schizophrenia, and Metabolic Syndrome in Non-Euro-American Societies
    Khalil, Rami Bou
    CLINICAL NEUROPHARMACOLOGY, 2012, 35 (03) : 141 - 147
  • [28] Improving Metabolic Syndrome Screening on Patients on Second Generation Antipsychotic Medication
    Kioko, Esther
    Williams, Kimberly
    Newhouse, Beth
    ARCHIVES OF PSYCHIATRIC NURSING, 2016, 30 (06) : 671 - 677
  • [29] Antipsychotic polypharmacy and metabolic syndrome in schizophrenia: a review of systematic reviews
    Ijaz, Sharea
    Bolea, Blanca
    Davies, Simon
    Savovic, Jelena
    Richards, Alison
    Sullivan, Sarah
    Moran, Paul
    BMC PSYCHIATRY, 2018, 18
  • [30] Reducing metabolic syndrome in Australian patients: Metabolic Management During Antipsychotic Prescribing (MMAP) programme
    Castle, David J.
    Hopwood, Malcolm
    Rege, Sanil
    George, David B.
    AUSTRALASIAN PSYCHIATRY, 2022, 30 (01) : 84 - 89
12345